Matter of Burrell v. West

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• explaining that the FDA “considers the [subsequent] drug to be different—and thus entitled to its own seven-year exclusivity period upon designation and approval—if it does not have the same active moiety or 5 is clinically superior”
• “Indeed, inherent in any sort of exclusivity period is a tradeoff between incentivizing research and development and promoting competition.”

Source: CourtListener parenthetical corpus (CC0).